Introduction and Objectives

The Adjustable Continence Therapy (ProACT™) was first used as a minimally invasive treatment for male stress urinary incontinence in 2000.

ABSTRACT

Introduction and Objectives: The loss of self-esteem and depressive symptoms have been previously reported in women with urinary incontinence. Low self-esteem and depression can have a profound effect on quality of life. The incidence of depression in the United Kingdom is estimated between 20 to 25% of women. Self-esteem, defined as the "belief and confidence in one’s own ability and value" is distinct from well being, confidence, and depression. Self-esteem and depression influence health-seeking and coping behaviours and perception of illness and treatment compliance, which are important factors in the successful management of lower urinary tract dysfunction. The objective of this study was to determine whether or not treatment of overactive bladder (OAB) was associated with improvement in self-esteem and depression in women, using validated questionnaires.

ABSTRACT

Introduction and Objectives: To estimate possibilities of use of long term neuroblocker - Botulotoxine type A (BoNTA) (BOTOX®) at patients with an Overactive Bladder resistant to anticholinergics therapy.

Introduction and Objectives

Loss of self esteem and depressive symptoms have been previously reported in women with urinary incontinence.

Introduction and Objectives

No population-based studies evaluating the prevalence of lower urinary tract symptoms (LUTS) in the US using the 2002 ICS definitions have been conducted.